The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP)

NCT02854722 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Deferasirox and calcium-vitamin D3
DRUG: Calcium-vitamin D3

Sponsor

Second Affiliated Hospital of Soochow University